TGTX Laurence N Charney sells $755K worth of shares
Nov 13, 2024, 5:31 AM
-9.75%
What does TGTX do
TG Therapeutics, based in Morrisville, North Carolina, develops treatments for B-cell malignancies and autoimmune diseases, with key candidates including Ublituximab, TG-1701, and TG-1801. The company employs 284 people and explores partnership opportunities for additional products.
Laurence N Charney sold 25,000 shares of TGTX on 11 November at $30.20 per share, worth a total of $755K. They now own 212,479 TGTX shares, or a 11% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.